Showing 1 - 20 of 82 trials – Showing only trials currently accepting patients
-
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
Stanford is currently accepting patients for this trial. -
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Stanford is currently accepting patients for this trial. -
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Stanford is currently accepting patients for this trial. -
Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
Stanford is currently accepting patients for this trial. -
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Stanford is currently accepting patients for this trial. -
Symptom Screening Linked to Care Pathways
Stanford is currently accepting patients for this trial. -
Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Stanford is currently accepting patients for this trial. -
Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone (BMT CTN 1705)
Stanford is currently accepting patients for this trial. -
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Stanford is currently accepting patients for this trial. -
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
Stanford is currently accepting patients for this trial. -
Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders
Stanford is currently accepting patients for this trial. -
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Stanford is currently accepting patients for this trial. -
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant
Stanford is currently accepting patients for this trial. -
Respiratory Virus Testing and Home Spirometry for the Screening of Bronchiolitis Obliterans Syndrome After Donor Stem Cell Transplant
Stanford is currently accepting patients for this trial. -
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Stanford is currently accepting patients for this trial. -
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
Stanford is currently accepting patients for this trial. -
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Stanford is currently accepting patients for this trial. -
Study of Kidney Tumors in Younger Patients
Stanford is currently accepting patients for this trial. -
Proof-of-concept Trial of Apraglutide in GVHD
Stanford is currently accepting patients for this trial. -
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Stanford is currently accepting patients for this trial.